Monolateral renal infarction and erythromelalgia in a case of chronic myelogenous leukemia.
Karin
K
Bernardini
Andrea Judith
AJ
Lanthaler
Thomas
T
Buratti
Manfred
M
Mitterer
D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001549:Benzamides; D004916:Erythromelalgia / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage; D000068877:Imatinib Mesylate; D007238:Infarction / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy; D016898:Interferon-alpha / Q000008:administration & dosage; D007668:Kidney / Q000098:blood supply* / Q000000981:diagnostic imaging; D007674:Kidney Diseases / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D010879:Piperazines / Q000008:administration & dosage; D011743:Pyrimidines / Q000008:administration & dosage; D011859:Radiography
D000970:Antineoplastic Agents; D001549:Benzamides; D016898:Interferon-alpha; D010879:Piperazines; D011743:Pyrimidines; D005047:Etoposide; D000068877:Imatinib Mesylate; D006918:Hydroxyurea